-
EP1082298
European procedure
Extract from the Register of European Patents
EP About this file: EP1082298
| EP1082298 - 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF [Right-click to bookmark this link] | |||
| Former [2001/11] | 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF | ||
| [2003/11] | Status | No opposition filed within time limit Status updated on 10.09.2004 Database last updated on 31.08.2024 | Most recent event Tooltip | 10.09.2004 | No opposition filed within time limit | published on 27.10.2004 [2004/44] | Applicant(s) | For all designated states BONE CARE INTERNATIONAL, INC. One Science Court Madison, WI 53711 / US | [2001/11] | Inventor(s) | 01 /
BISHOP, Charles, W. 5 LaPointe Terrace Madison, WI 53719 / US | 02 /
KNUTSON, Joyce, C. 24 North Prospect Avenue Madison, WI 53705 / US | 03 /
STRUGNELL, Stephen 2622 Dahle Street Madison, WI 53704 / US | [2001/11] | Representative(s) | Nicholls, Kathryn Margaret, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2001/11] | Nicholls, Kathryn Margaret, et al MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 99928357.5 | 28.05.1999 | [2001/11] | WO1999US12062 | Priority number, date | US19980087439 | 29.05.1998 Original published format: US 87439 | [2001/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9961418 | Date: | 02.12.1999 | Language: | EN | [1999/48] | Type: | A2 Application without search report | No.: | EP1082298 | Date: | 14.03.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.12.1999 takes the place of the publication of the European patent application. | [2001/11] | Type: | B1 Patent specification | No.: | EP1082298 | Date: | 05.11.2003 | Language: | EN | [2003/45] | Search report(s) | International search report - published on: | EP | 23.03.2000 | Classification | IPC: | C07C401/00 | [2001/11] | CPC: |
A61K31/593 (EP,US);
A61K31/59 (EP,US);
A61K31/592 (EP,US);
A61P13/08 (EP);
A61P17/06 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P29/00 (EP);
A61P3/14 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
A61P5/18 (EP)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, IE, IT, LI, LU, NL, PT, SE [2001/11] | Title | German: | 1ALPHA-HYDROXY-25-ENE-VITAMIN D, DEREN ANALOGEN UND VERWENDUNG DAVON | [2001/11] | English: | 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF | [2003/11] | French: | COMPOSES DE 1-alpha-HYDROXY-25-ENE-VITAMINE D, LEURS ANALOGUES, ET LEURS UTILISATIONS | [2003/11] |
| Former [2001/11] | 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF | ||
| Former [2001/11] | COMPOSES DE 1$g(a)-HYDROXY-25-ENE-VITAMINE D, LEURS ANALOGUES, ET LEURS UTILISATIONS | Entry into regional phase | 18.12.2000 | National basic fee paid | 18.12.2000 | Designation fee(s) paid | 18.12.2000 | Examination fee paid | Examination procedure | 22.12.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 18.12.2000 | Examination requested [2001/11] | 30.09.2002 | Despatch of a communication from the examining division (Time limit: M02) | 09.12.2002 | Reply to a communication from the examining division | 27.02.2003 | Communication of intention to grant the patent | 22.08.2003 | Fee for grant paid | 22.08.2003 | Fee for publishing/printing paid | Opposition(s) | 06.08.2004 | No opposition filed within time limit [2004/44] | Fees paid | Renewal fee | 22.05.2001 | Renewal fee patent year 03 | 28.05.2002 | Renewal fee patent year 04 | 26.05.2003 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US4481198 (DELUCA HECTOR F [US], et al)[A] 1-19; | [A]WO9700242 (SCHERING AG [DE], et al) [A] 1-19; | [A]WO9720811 (LEO PHARM PROD LTD [DK], et al) [A] 1-19 |